Maria Dolores
Chirlaque Lopez
Asociado a Tiempo Parcial
![Foto de Rafael](/img/nophoto.png)
Rafael
Marcos Gragera
Publicaciones en las que colabora con Rafael Marcos Gragera (86)
2024
-
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study
The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307
-
Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study
The Lancet Oncology, Vol. 25, Núm. 6, pp. 731-743
2023
-
Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage
Frontiers in Oncology, Vol. 13
-
Childhood and Adolescent Central Nervous System Tumours in Spain: Incidence and Survival over 20 Years: A Historical Baseline for Current Assessment
Cancers, Vol. 15, Núm. 24
-
Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes
Frontiers in Oncology, Vol. 13
-
Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3)
Neuro-Oncology, Vol. 25, Núm. 3, pp. 593-606
-
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)
Neuro-Oncology, Vol. 25, Núm. 3, pp. 580-592
-
Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983–2018
Frontiers in Oncology, Vol. 13
2022
-
Cancer Survival in Adults in Spain: A Population-Based Study of the Spanish Network of Cancer Registries (REDECAN)
Cancers, Vol. 14, Núm. 10
-
Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials
Frontiers in Oncology, Vol. 12
-
Incidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN)
Frontiers in Oncology, Vol. 12
-
Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries
The Lancet Regional Health - Europe, Vol. 21
-
Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study
The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 8, pp. 711-723
-
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries
The Lancet Child and Adolescent Health, Vol. 6, Núm. 6, pp. 409-431
2021
-
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
The Lancet Oncology, Vol. 22, Núm. 7, pp. 1002-1013
-
Kaposi sarcoma incidence, survival and trends: Data from the information network on rare cancers in Europe (RARECAREnet)
Cancer Epidemiology, Vol. 70
-
Social mobility and healthy behaviours from a gender perspective in the Spanish multicase-control study (MCC-Spain)
PLoS ONE, Vol. 16, Núm. 5 May
-
Study protocol on Socioeconomic and Geographic Inequalities in Cancer Incidence, Mortality and Survival in Spain: Multilevel Population-Base Study: DESOCANES study
Gaceta Sanitaria, Vol. 35, Núm. 2, pp. 199-203
-
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)
Neuro-Oncology, Vol. 23, Núm. 10, pp. 1765-1776
-
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
Cancer, Vol. 127, Núm. 16, pp. 2934-2942